Abstract| Volume 11, ISSUE 3, P790, May 2017

Cost Effective Model for Genomic Screening for Familial Hypercholesterolemia Mutations in Populations With High LDL Cholesterol Levels

      Speakers Bureaus: Sanofi, Regeneron, Amgen, Janssen, Amarin and Quest Diagnostics; Clinical Investigator: Sanofi, Regeneron, FH Foundation
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Clinical Lipidology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect